Optimizing MRI Protocols for Brain Radiosurgery: The Role of Sequence and Contrast Agent Timing

Accurate target volume delineation is critical for effective stereotactic radiotherapy (SRT) of brain metastases. This study systematically investigates how MRI sequence selection and the time elapsed after contrast agent (CA) administration affect the apparent metastases volumes, with the goal of optimizing MRI protocols for radiation therapy planning.

A total of 49 patients with 414 brain metastases were included and randomized into 6 groups with varying imaging sequences (MPRAGE, SPACE, and VIBE) and timepoints after CA administration. Lesions smaller than 0.03 cm3 were excluded due to resolution limitations. Lesion volumes were independently assessed by radiology and radiation oncology specialists, and mean values were analyzed. The effects of MRI sequence and time delay on lesion volume were evaluated using t tests, ANOVA, and multiple linear regression.

Both MRI sequence and CA timing significantly influenced measured volumes. On average, SPACE volumes were 20% larger than MPRAGE, and VIBE volumes were 10% larger than SPACE, independent of timing. Lesion volumes increased progressively with time after CA administration at rates of 0.63%, 0.58%, and 0.36% per minute for MPRAGE, SPACE, and VIBE, respectively. Smaller lesions (<1 cm3) showed greater relative intersequence differences, primarily due to variations in visible lesion borders.

Both MRI sequence choice and imaging time after CA administration significantly affect the apparent volume of brain metastases in SRT planning. Although SPACE and VIBE sequences enhance small lesion detection, they may also increase border blurring and inter-rater variability. Standardizing protocols to account for these factors is essential for improving delineation accuracy, reducing toxicity risk, and optimizing SRT outcomes.